MaxCyte, Inc. Inventory Write-down
MaxCyte, Inc. (MXCT) reported Inventory Write-down of $379.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-13
- MaxCyte, Inc. inventory write-down for the quarter ending 2026-06-30 was $182.00K, a 82.00% increase year-over-year.
- MaxCyte, Inc. inventory write-down for the quarter ending 2026-03-31 was $197.00K, a 203.08% increase year-over-year.
- MaxCyte, Inc. inventory write-down for the quarter ending 2025-12-31 was $151.00K, a 83.88% decline year-over-year.
- MaxCyte, Inc. inventory write-down for the quarter ending 2025-09-30 was $360.00K, a 48.35% decline year-over-year.
- MaxCyte, Inc. inventory write-down for fiscal 2025 was $676.00K, a 61.83% decline from fiscal 2024.
- MaxCyte, Inc. inventory write-down for fiscal 2024 was $1.77M, a 154.09% increase from fiscal 2023.
- MaxCyte, Inc. inventory write-down for fiscal 2023 was $697.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $379.00K 10-Q · filed 2026-08-13 | $530.00K derived: sum of 3 quarters · filed 2026-08-13 | $890.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $197.00K 10-Q · filed 2026-05-13 | $348.00K derived: sum of 2 quarters · filed 2026-05-13 | $708.00K derived: sum of 3 quarters · filed 2026-05-13 | $808.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $511.00K derived: sum of 2 quarters · filed 2026-03-25 | $611.00K derived: sum of 3 quarters · filed 2026-08-13 | $676.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $460.00K derived: sum of 2 quarters · filed 2026-08-13 | $525.00K 10-Q · filed 2025-11-13 | $1.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $165.00K 10-Q · filed 2026-08-13 | $1.10M derived: sum of 3 quarters · filed 2026-08-13 | $1.80M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $65.00K 10-Q · filed 2026-05-13 | $1.00M derived: sum of 2 quarters · filed 2026-05-13 | $1.70M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.63M derived: sum of 2 quarters · filed 2026-03-25 | $1.77M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $697.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $834.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $137.00K 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $697.00K 10-K · filed 2025-03-11 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-09-13 | |||
| 2020-12-31 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |